Cytosorbents CEO Phillip Chan's 2022 pay falls 38% to $1.1M
Cytosorbents reports 2022 executive compensation
By ExecPay News
Published: April 21, 2023
Cytosorbents reported fiscal year 2022 executive compensation information on April 21, 2023.
In 2022, four executives at Cytosorbents received on average a compensation package of $987K, a 31% decrease compared to previous year.
Average pay of disclosed executives at Cytosorbents
Phillip P. Chan, Chief Executive Officer, received $1.1M in total, which decreased by 38% compared to 2021. 44% of Chan's compensation, or $483K, was in salary. Chan also received $47K in bonus, $411K in option awards, $154K in stock awards, as well as $12K in other compensation.
Efthymios N. Deliargyris, Chief Medical Officer, received a compensation package of $1M, which decreased by 16% compared to previous year. 44% of the compensation package, or $444K, was in option awards.
Vincent J. Capponi, Chief Operating Officer, earned $986K in 2022, a 34% decrease compared to previous year.
Kathleen P. Bloch, Chief Financial Officer, received $848K in 2022, which decreases by 32% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 21, 2023.